
Advertise on podcast: GTSC Podcast
Rating
5from
This podcast has
7 episodes
Language
EnglishPublisher
General Thoracic Surgical ClubExplicit
No
Date created
2023/10/25
Latest episode
2026/08/05
Average duration
47 min.
Release period
169 days
Description
Periodic updates from the General Thoracic Surgical Club.
Unlock GTSC Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from GTSC Podcast podcast
Borderline Resectability
2026/08/05
In this GTSC podcast, Dr. Elliot Servais joins Dr. Jessica Donington and Dr. Biniam Kidane to explore the complex judgment involved in assessing resectability in the era of perioperative chemoimmunotherapy. The discussion highlights the critical distinctions among technical, oncologic, and physiologic resectability, as well as the essential role of surgeons and the multidisciplinary team in guiding treatment decisions.
Lung Nodule Localization Prior To Thoracic Surgery
2025/10/21
In this episode of the General Thoracic Surgical Podcast, Dr. Linda Martin and Dr. Rishi Reddy explore the rapidly evolving landscape of lung nodule localization—a critical topic as thoracic surgeons increasingly encounter smaller, non-palpable nodules due to expanded screening and imaging practices.
The conversation covers the full spectrum of localization techniques—from traditional wire and dye marking to advanced robotic bronchoscopy, ICG (indocyanine green) fluorescence, and molecular imaging agents such as CYTALUX® (pafolacianine) injection. The discussion highlights workflow integration, patient safety, cost considerations, and the implications of emerging bronchoscopic ablation and molecular-targeted visualization technologies on the future of thoracic oncology.
This episode is proudly sponsored by On Target Laboratories.
Changes in Early-Stage Lung Cancer Treatments Options
2025/08/18
In this podcast, Drs. Linda Martin (UVA) and Dennis Wigle (Mayo Clinic Rochester, MN) discuss key updates in the treatment of early stage surgically resectable non small cell lung cancer from the 2025 American Society of Clinical Oncology Annual Meeting. Topics include updated survival data from the CheckMate 816 trial of neoadjuvant nivolumab plus chemotherapy, the practice impact of PROSPECT lung accrual, and results from the NeoADAURA trial of neoadjuvant osimertinib. This episode was sponsored by BMS.
N2 Disease - Are There Any Rules Anymore!
2024/09/18
In this podcast, Drs. Linda Martin and Jessica Donington discuss the evolving approach to treating N2 disease in stage 3 lung cancer, emphasizing the shift from therapeutic nihilism to more aggressive surgical strategies. They highlight the success of combining chemotherapy, immunotherapy, and surgery, which has led to improved outcomes, especially in patients with multi-station N2 disease, while noting the importance of rethinking traditional treatment paradigms and focusing on systemic control rather than local clearance alone.
ALINA Trial and Adjuvant Therapy
2024/06/18
In this episode of the GTSC podcast, Dr. Dennis Wigle (Mayo Clinic) and Dr. Linda Martin (UVA) review the recently published ALINA trial of adjuvant alectinib for resected ALK-positive NSCLC. We also review recently presented lung and esophageal cancer data from ASCO 2024, including ESOPEC, CheckMate 816 and 77T, AEGEAN, and the LU002 trial results for oligometastatic lung cancer. This podcast is sponsored by Genentech.
ESMO Meeting Update & Looking Ahead to 2024
2024/01/08
Dennis Wigle and Linda Martin from Mayo Clinic and University of Virginia, respectively, discuss recent trials from the meeting of the European Society for Medical Oncology (ESMO), particularly highlighting the ALINA trial focusing on adjuvant treatments for resected non small cell lung cancers with impressive differences in outcomes between Alectinib and platinum-based chemotherapy. In addition, they provide a review of multiple perioperative immunotherapy trials from 2023 and share their hopes for the field in 2024. This podcast is sponsored by Genentech.
What's new in Thoracic Surgery for lung cancer
2023/10/30
Drs. Linda Martin (University of Virginia) and Dennis Wigle (Mayo Clinic) review recent clinical trial publications on sublobar resection for early stage lung cancer, and the use of immunotherapy before surgery for later stage (locally advanced) lung cancer. We review the studies involved and provide perspective on the results and what they mean for patient care. This podcast is sponsored by Genentech.
Podcast sponsorship advertising
Start advertising on GTSC Podcast relevant audience podcasts
You may also like to advertise on these Podcasts

4.4503509
Warfare
History Hit

4.8296932000
Fantasy Footballers - Fantasy Football Podcast
Fantasy Football

4.712851555
True Crime All The Time
Emash Digital

4.8160231996
Watch What Crappens
Ben Mandelker & Ronnie Karam

4.639261172
Modern Wisdom
Chris Williamson

4.66262310
True Crime with Kendall Rae
Mile Higher Media & Audioboom Studios

4.73454788
The Ancients
History Hit

4.89189317
The Why Files: Operation Podcast
The Why Files: Operation Podcast

51088171
Middle Children
Jessie Jolles and Chris Burns

4.8265192000
Morning Wire
The Daily Wire